genentech press releases
「genentech press releases」熱門搜尋資訊
![genentech press releases](https://i0.wp.com/api.multiavatar.com/genentech+press+releases.png?apikey=viVnb6N20jclO8)
「genentech press releases」文章包含有:「PressReleases」、「Media」、「NewsFeatures」、「Genentech:PressReleases|Thursday」、「Genentech:PressReleases|Friday」、「Genentech:PressReleases|Monday」、「Genentech:PressReleases|Thursday」、「genentech」、「Genentech」、「Genentech:PressReleases|Monday」
查看更多![Press Releases](https://api.multiavatar.com/Press+Releases.png?apikey=viVnb6N20jclO8)
Press Releases
https://www.gene.com
Press Releases. Discover the latest news about our company, our products, our policies, and our people. 426 Results. Date, Title, Tags ...
![Media](https://api.multiavatar.com/Media.png?apikey=viVnb6N20jclO8)
Media
https://www.gene.com
Get access to Genentech information and resources for stories in development. Find recent and archived press releases. All Media; News Features
![News Features](https://api.multiavatar.com/News+Features.png?apikey=viVnb6N20jclO8)
News Features
https://www.gene.com
Read press releases and learn about our presence at ASH this year. 1 Nov 2013. FDA Approves New Genentech Medicine for Chronic Lymphocytic Leukemia (CLL) Gazyva.
![Genentech: Press Releases | Thursday](https://api.multiavatar.com/Genentech%3A+Press+Releases+%7C+Thursday%2C+Jul+4%2C+2024.png?apikey=viVnb6N20jclO8)
Genentech: Press Releases | Thursday
https://www.gene.com
“We are pleased that the U.S. FDA has approved the Vabysmo PFS for people living with wet AMD, DME and RVO, which are some of the leading causes ...
![Genentech: Press Releases | Friday](https://api.multiavatar.com/Genentech%3A+Press+Releases+%7C+Friday%2C+Jun+7%2C+2024.png?apikey=viVnb6N20jclO8)
Genentech: Press Releases | Friday
https://www.gene.com
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new 5-year data confirming the sustained efficacy and ...
![Genentech: Press Releases | Monday](https://api.multiavatar.com/Genentech%3A+Press+Releases+%7C+Monday%2C+May+20%2C+2024.png?apikey=viVnb6N20jclO8)
Genentech: Press Releases | Monday
https://www.gene.com
D., Genentech's chief medical officer and head of Global Product Development. “This promising inavolisib-based regimen could transform the PI3K ...
![Genentech: Press Releases | Thursday](https://api.multiavatar.com/Genentech%3A+Press+Releases+%7C+Thursday%2C+Apr+18%2C+2024.png?apikey=viVnb6N20jclO8)
Genentech: Press Releases | Thursday
https://www.gene.com
Alecensa is now the first and only ALK inhibitor approved for people with ALK-positive early-stage NSCLC who have undergone surgery to remove ...
![genentech](https://api.multiavatar.com/genentech%2C%2Binc.+News+%26amp%3B+Press+Releases.png?apikey=viVnb6N20jclO8)
genentech
https://www.prnewswire.com
News from genentech,+inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/ ...
![Genentech](https://api.multiavatar.com/Genentech.png?apikey=viVnb6N20jclO8)
Genentech
https://twitter.com
Genentech: Press Releases | Tuesday, Jul 16, 2024 · From gene.com. 7. 42 ... Genentech: Press Releases | Monday, Jul 8, 2024. From gene.com. 5.
![Genentech: Press Releases | Monday](https://api.multiavatar.com/Genentech%3A+Press+Releases+%7C+Monday%2C+Jul+8%2C+2024.png?apikey=viVnb6N20jclO8)
Genentech: Press Releases | Monday
https://www.gene.com
The FDA has approved updates to Susvimo, which will be available to U.S. retina specialists and patients with wet AMD in the coming weeks.